Prostate Cancer - Results from #27380

Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancer - Abstract August 3, 2011

Prostate derived ETS factor (PDEF): A putative tumor metastasis suppressor - Abstract August 3, 2011

The association of robotic surgical technology and hospital prostatectomy volumes: Increasing market share through the adoption of technology - Abstract August 2, 2011

Clamp ablation of the testes compared to bilateral orchiectomy as androgen deprivation therapy for advanced prostate cancer - Abstract August 2, 2011

EAU guidelines on prostate cancer. P5art I: Screening, diagnosis, and treatment of clinically localised disease - Abstract August 2, 2011

Role of endorectal magnetic resonance spectroscopic imaging in two different Gleason scores in prostate cancer - Abstract August 2, 2011

Psychosocial adjustment of men during the first year of prostate cancer - Abstract August 2, 2011

Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: Study of a US population - Abstract August 2, 2011

Testosterone regulates tight junction proteins and influences prostatic autoimmune responses - Abstract August 2, 2011

First multi-site study evaluates new targeted radiation approach for shortened, safer prostate cancer treatment August 2, 2011

Editor's Commentary - Dealing with a troublesome body: A qualitative interview study of men's experiences living with prostate cancer treated with endocrine therapy August 2, 2011

Surgical castration in hormone-refractory metastatic prostate cancer patients can be an alternative for medical castration - Abstract August 1, 2011

Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling - Abstract August 1, 2011

The use of estramustine phosphate in the modern management of advanced prostate cancer - Abstract August 1, 2011

Oncological and functional outcomes following open radical prostatectomy: How patients may achieve the ″trifecta″? - Abstract August 1, 2011

Biochemical recurrence after radical prostatectomy: Is the disease or the surgeon to blame? - Abstract August 1, 2011

Editor's Commentary - Physical activity after diagnosis and risk of prostate cancer progression: Data from the cancer of the prostate strategic urologic research endeavor August 1, 2011

Prostate cancer diagnostics: Innovative imaging in case of multiple negative biopsies - Abstract July 29, 2011

No association of type-2 diabetes risk variants and prostate cancer risk: The Multiethnic Cohort and PAGE - Abstract July 29, 2011

In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen - Abstract July 29, 2011

Page 1370 of 1436